Discontinuation report GLUCOBAY
| Report ID | 198128 |
| Drug Identification Number | 02190893 |
| Brand name | GLUCOBAY |
| Common or Proper name | ACARBOSE |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACARBOSE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 120's |
| ATC code | A10BF |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-07-10 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-07-11 | French | Compare |
| v1 | 2023-07-11 | English | Compare |
Showing 1 to 2 of 2